1. 297 Leap-005: evaluating the safety and efficacy of lenvatinib and pembrolizumab in patients previously treated for ovarian cancer, a multi-cohort phase 2 study. (4th December 2020) Authors: Gonzalez-Martin, Antonio; Chung, Hyun Cheol; Saada-Bouzid, Esma; Yanez, Eduardo; Senellart, Hélène; Cassier, Philippe A; Basu, Bristi; Ghori, Razi; Kubiak, Peter; Smith, Alan; Norwood, Kevin; Lwin, Zarnie Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies. Issue 11 (November 2009) Authors: Basu, Bristi; Biswas, Swethajit; Wrigley, Jessica; Sirohi, Bhawna; Corrie, Pippa Journal: Expert review of anticancer therapy Issue: Volume 9:Issue 11(2009) Page Start: 1583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antiangiogenesis in cancer therapy. ([2014]) Editors: Basu, Bristi; Biswas, Swethajit; Pacey, Simon Record Type: Book Extent: 1 online resource (159 pages), illustrations (chiefly colour) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development of a Prognostic Model That Predicts Survival After Pancreaticoduodenectomy for Ampullary Cancer. Issue 10 (November 2017) Authors: Feretis, Michael; Wang, Tengyao; Iype, Satheesh; Duckworth, Adam; Brais, Rebecca; Basu, Bristi; Jamieson, Neville V.; Huguet, Emmanuel; Balakrishnan, Anita; Jah, Asif; Praseedom, Raaj K.; Harper, Simon J.; Liau, Siong-Seng Journal: Pancreas Issue: Volume 46:Issue 10(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer. Issue 6 (July 2015) Authors: Sayal, Karen; Gounaris, Ioannis; Basu, Bristi; Freeman, Sue; Moyle, Penny; Hosking, Karen; Iddawela, Mahesh; Jimenez-Linan, Mercedes; Abraham, Jean; Brenton, James; Hatcher, Helen; Earl, Helena; Parkinson, Christine Journal: International journal of gynecological cancer Issue: Volume 25:Issue 6(2015:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study. Issue 6 (1st July 2015) Authors: Sayal, Karen; Gounaris, Ioannis; Basu, Bristi; Freeman, Sue; Moyle, Penny; Hosking, Karen; Iddawela, Mahesh; Jimenez-Linan, Mercedes; Abraham, Jean; Brenton, James; Hatcher, Helen; Earl, Helena; Parkinson, Christine Journal: International journal of gynecological cancer Issue: Volume 25:Issue 6(2015:Jul.) Page Start: 977 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience. Issue 3 (March 2016) Authors: Gounaris, Ioannis; Iddawela, Mahesh; Parkinson, Christine; Pratt, Jennie; Hatcher, Helen; Basu, Bristi; Tan, Li Tee; Brenton, James D.; Earl, Helena M. Journal: Anti-cancer drugs Issue: Volume 27:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Intermittent schedules of the oral RAF–MEK inhibitor CH5126766/VS-6766 in patients with RAS/RAF-mutant solid tumours and multiple myeloma: a single-centre, open-label, phase 1 dose-escalation and basket dose-expansion study. Issue 11 (November 2020) Authors: Guo, Christina; Chénard-Poirier, Maxime; Roda, Desamparados; de Miguel, Maria; Harris, Samuel J; Candilejo, Irene Moreno; Sriskandarajah, Priya; Xu, Wen; Scaranti, Mariana; Constantinidou, Anastasia; King, Jenny; Parmar, Mona; Turner, Alison J; Carreira, Suzanne; Riisnaes, Ruth; Finneran, Laura; ... Journal: Lancet oncology Issue: Volume 21:Issue 11(2020) Page Start: 1478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Progress in pancreatic cancer: moving beyond gemcitabine?. Issue 8 (August 2012) Authors: Basu, Bristi; Jodrell, Duncan Journal: Expert review of anticancer therapy Issue: Volume 12:Issue 8(2012) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Progress in pancreatic cancer: moving beyond gemcitabine?. Issue 8 (August 2012) Authors: Basu, Bristi; Jodrell, Duncan Journal: Expert review of anticancer therapy Issue: Volume 12:Issue 8(2012) Page Start: 997 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗